Clinical Trial Led by Professor Michael Reade Ensures Platelets Survive the Freezing and Thawing Process
Ganesh Mohan, Professor at Kasturba Medical College, Manipal, reposted from The University of Queensland on LinkedIn:
“Promising signs and interesting days ahead as a transfusion medicine specialist”
Quoting The University of Queensland’s post:
“The shelf life of life-saving platelet transfusions for patients with significant bleeding has just been dramatically extended – from a week to 2 years.
UQ and Australian Red Cross Lifeblood research shows that freezing the platelets made them only slightly less effective and still stopped blood loss.
Obstetrics and gastrointestinal patients, as well as those injured in accidents or combat zones, are among those who need transfusions.
The limited shelf life currently means 25–33% of platelet units are discarded worldwide, and there are often no platelets available in rural and remote areas.
The results from a clinical trial led by Professor Michael Reade builds on a decade of research to ensure platelets could survive the freezing and thawing process.
Together, these findings will change the international management of blood supplies, saving lives around the world.
You can read the full story here.

Professor Michael Reade AM holding bag of platelets at ARC Lifeblood Brisbane.”
Get insights from Hemostasis Today.
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis